Growth I. Lp Medicxi serves as Executive at Centessa Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Growth I. Lp Medicxi has executed 12 insider transactions totaling $11.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 1, 2021 involved purchasing 58,905 shares valued at $743.4K.
Growth I. Lp Medicxi currently holds 3,903,440 shares of Centessa Pharmaceuticals plc (CNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Growth I. Lp Medicxi has been a net buyer of CNTA stock. They have purchased $11.9M and sold $0 worth of shares.
Growth I. Lp Medicxi's most recent insider trade was on Dec 1, 2021, when they purchased 58,905 shares at $12.62 per share.
Get notified when new Form 4 filings are submitted
| $12.62 |
| Discretionary |
| Nov 30, 2021 | CNTA | $9.9K | Purchase | 855 | $11.62 | Discretionary |
| Nov 30, 2021 | CNTA | $418.2K | Purchase | 35,992 | $11.62 | Discretionary |
| Nov 29, 2021 | CNTA | $15.4K | Purchase | 1,315 | $11.70 | Discretionary |
| Nov 29, 2021 | CNTA | $648.1K | Purchase | 55,391 | $11.70 | Discretionary |
| Nov 26, 2021 | CNTA | $3.1K | Purchase | 274 | $11.34 | Discretionary |
| Nov 26, 2021 | CNTA | $130.9K | Purchase | 11,543 | $11.34 | Discretionary |
| Nov 2, 2021 | AURA | $0 | Conversion | 54,065 | $N/A | Discretionary |
| Nov 2, 2021 | AURA | $230.7K | Purchase | 16,475 | $14.00 | Discretionary |
| Nov 2, 2021 | AURA | $0 | Conversion | 2,275,827 | $N/A | Discretionary |
| Nov 2, 2021 | AURA | $9.7M | Purchase | 693,525 | $14.00 | Discretionary |